This inventor holds 1 USPTO granted patent. Top assignee: The Cleveland Clinic Foundation. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Xing Chen
Introduction
Xing Chen is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of biomedical research, particularly in the development of transgenic models for studying neurological conditions. His work is instrumental in advancing our understanding of gene functions and their implications in diseases.
Latest Patents
Xing Chen holds a patent for "Transgenic mice with inducible neuron-specific inactivation of HuR gene and method of screening." This patent describes non-human transgenic animals that either under-express or do not express the Hu Antigen R (HuR) gene in specific neurons. These models are crucial for screening drugs and therapies, particularly those aimed at treating conditions such as Amyotrophic Lateral Sclerosis (ALS).
Career Highlights
Xing Chen is affiliated with the Cleveland Clinic Foundation, where he conducts research that bridges the gap between genetics and therapeutic applications. His innovative approach to creating transgenic models has garnered attention in the scientific community, highlighting the potential for new treatment strategies.
Collaborations
Xing Chen collaborates with esteemed colleagues, including Kevin Sun and Tomasz Herjan. Their combined expertise fosters a dynamic research environment that enhances the development of novel therapeutic approaches.
Conclusion
Xing Chen's contributions to the field of biomedical research through his innovative patents and collaborative efforts are paving the way for advancements in the treatment of neurological diseases. His work exemplifies the impact of scientific innovation on healthcare.